A detailed history of Vident Advisory, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 5,867 shares of BAX stock, worth $173,076. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,867
Holding current value
$173,076
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.85 - $40.26 $192,730 - $236,205
5,867 New
5,867 $223 Million
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $42,046 - $48,584
-1,110 Reduced 13.18%
7,312 $313 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $30,885 - $37,937
-974 Reduced 10.37%
8,422 $326 Million
Q3 2023

Feb 21, 2024

BUY
$37.32 - $49.29 $36,349 - $48,008
974 Added 11.56%
9,396 $355 Million
Q3 2023

Nov 14, 2023

BUY
$37.32 - $49.29 $350,658 - $463,128
9,396 New
9,396 $355 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.